LB PHARMACEUTICALS INC (LBRX) Options Statistics & Positioning
LB PHARMACEUTICALS INC (LBRX) options trade at a 30-day at-the-money implied volatility of 116.9%, an IV rank of 31 out of 100 over the past year. The options market prices a ±$5.39 (±16.2%) move in LBRX for the front expiration. Max pain sits at $22.5 and the put/call open interest ratio is 0.79. Statistics are computed by OptiView from delayed OPRA options data and refresh every trading day.
Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.
Most Active LBRX Contracts
| Contract | Expiration | DTE | Last | IV | Volume |
|---|---|---|---|---|---|
| LBRX $40 call | Jan 15, 2027 | 189d | $6.00 | 93.3% | 5 |
Explore LBRX Options Statistics
Explore the payoff profile of option on LBRX for free
Build multi-leg LBRX strategies, visualize payoffs, and scan the full US options universe with OptiView.
LBRX Options FAQ
How often is LBRX options data on this page updated?
All LBRX statistics on this page are computed by OptiView from delayed OPRA options data and refresh every trading day after the session close.
Where can I see LBRX max pain, open interest, and implied volatility in detail?
OptiView publishes dedicated LBRX pages for implied volatility, max pain, open interest, gamma exposure, options volume, and the most active contracts — each with charts, history, and a plain-English explanation of what the numbers mean.
Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.
Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.